Posted on

Patient Choice Award Recipients – 2025

We are pleased to report that 5 of the pediatric endocrinology providers in our division have received Patient Choice Awards. These awards are given out by UI Health Care to recognize physicians for consistently providing patients with an excellent healthcare experience with ratings in the top 10% nationally. The recipient physicians were:

Dr. Pesce honored for 5 years of Patient Choice Awards. Here she is joined by her husband who also received a Patient Choice award.
  • Vanessa Curtis, MD
  • Katie Larson Ode, MD
  • Liuska Pesce, MD
  • Akhila Ramakrishna, MD
  • Julie Osterhaus, ARNP

Dr. Pesce was furthermore recognized for having received the award for 5 consecutive years.

The Choice Award was earned by only 276 outpatient providers across the entire institution. The Award recognizes those who scored in the top 10% nationally in response to patient surveys asking whether the physician showed concern for patient questions or worries, gave explanations about problem or condition, made efforts to include the patient in care decisions, discussed proposed treatments (options, risks, benefits, etc), and whether they would be likely to recommend the care provider to others. Our division is fortunate to have these Award winning physicians on our team. We thank each of them for their wonderful work.

Posted on

Balancing Confidentiality and Care: Dr. Kanner Helps Shape Guidelines

Dr. Kanner

We are proud to share that Dr. Kanner has helped author an important new publication in the Journal of Pediatric and Adolescent Gynecology (December 2025 issue). The manuscript, titled “NASPAG Clinical Consensus on Adolescent Pregnancy Testing: Balancing Confidentiality, Consent, and Disclosure” addresses a critical aspect of adolescent reproductive health care.

This consensus document, developed by members of the North American Society for Pediatric and Adolescent Gynecology (NASPAG), provides clinicians with a framework for counseling adolescent patients who present with a positive pregnancy test. It explores the legal, ethical, and clinical considerations involved in guiding patients through the testing process, including strategies for ordering tests, disclosing results, and managing care when a pregnancy is confirmed. The review emphasizes the importance of individualized, patient-centered approaches, mindful of varying clinical, institutional, and legal scenarios. The abstract for this publication is available on PubMed at https://pubmed.ncbi.nlm.nih.gov/41371579/. This work represents a significant contribution to the important ongoing dialogues about adolescent health care. We thank Dr. Kanner for her efforts relating to this challenging topic.

Posted on

Drs. Castano & Palmer Pass Boards!

Dr. Palmer
Dr. Castaño

It takes years of training to become a pediatric endocrinologist, requiring at least a decade of studies after college. You could consider this to be the equivalent of completing the “26th grade”. The final step is to pass the Pediatric Endocrinology board exam. We are pleased to report that the two newest doctors in our Division have just passed their Board Exam. Congratulations to Dr. Castano and Dr. Palmer for becoming Board Certified Pediatric Endocrinologists. Their years of hard work and study have enabled them to become fully qualified to diagnose and treat pediatric endocrine conditions.

Posted on

Muscle “Recycling Centers” Helps Prevent Type 2 Diabetes

Dr. Norris

A group of researchers have identified a key protein complex in muscle cells that regulates the body’s response to nutrients and helps maintain healthy blood sugar levels. The researchers focused on the role of this complex, known as LRRC8, in muscle lysosomes. Lysosomes are tiny compartments inside cells that act like recycling centers. The researchers found that lysosomal LRRC8 plays a critical role in governing cellular growth and metabolism. When LRRC8 was disrupted in lab-grown muscle cells, lysosomal function was impaired, weakening how muscle cells responded to nutrients and to insulin. Furthermore, mice lacking lysosomal LRRC8 developed increased body fat, insulin resistance, and poor glucose tolerance — conditions closely linked to type 2 diabetes. This research uncovers a previously unknown connection between LRRC8 lysosomal function in muscle cells and whole-body metabolic health, opening new avenues for understanding and potentially treating metabolic diseases such as type 2 diabetes. Dr. Norris from our division was part of the research team and is a co-author on the manuscript. The peer-reviewed findings are published in Science Advances under the title: “Lysosomal LRRC8 complex impacts lysosomal pH, morphology, and systemic glucose metabolism.” The abstract is available on PubMed: https://pubmed.ncbi.nlm.nih.gov/41004571/.

Posted on

Advancing Expert Diagnosis and Care for Pancreatogenic Diabetes

Dr. Larson Ode
Dr. Norris

Pancreatogenic diabetes is an underrecognized form of diabetes that develops as a consequence of diseases affecting the exocrine pancreas. Though often overshadowed by type 1 and type 2 diabetes, pancreatogenic diabetes is estimated to account for 1–9% of all diabetes cases, making it a significant contributor to global health burden. This condition can arise from a range of pancreatic disorders, including pancreatitis, pancreatic cancer, cystic fibrosis, surgical removal of the pancreas, and fibrocalculous pancreatic disease. Each of these conditions presents unique diagnostic and therapeutic challenges, underscoring the need for heightened clinical awareness. Two faculty members from our Division, Dr. Larson Ode and Dr. Norris, have authored a comprehensive clinical review on this topic, recently accepted for publication in the Journal of Clinical Endocrinology and Metabolism (JCEM), one of the leading journals in the field.

Their article, titled “Approach to the Patient with Pancreatogenic Diabetes”, synthesizes current evidence and offers practical guidance for clinicians managing these complex cases. The work was co-authored by adult endocrinologist Dr. Yumi Imai. The review emphasizes the importance of timely diagnosis and tailored treatment. For instance, diabetes can be an early warning sign of pancreatic cancer—a disease with poor prognosis and no reliable biomarkers—making clinical suspicion critical. In cystic fibrosis, even mild diabetes can worsen lung function and increase mortality risk, highlighting the need for proactive screening. The authors also discuss the frequent coexistence of exocrine pancreatic insufficiency in these patients, noting that in these cases pancreatic enzyme replacement therapy may improve glycemic control.

We are glad that these authors have been able to bring their recognized expertise in pancreatogenic diabetes to this work, providing clinicians with actionable insights into evolving screening and treatment strategies. The article’s abstract can be found on PubMed (https://pubmed.ncbi.nlm.nih.gov/41252284/), where there are links to the open access full manuscript.

Posted on

What Mechanisms Drive Diabetes-Risk in Youth with Pancreatitis?

Dr. Larson Ode
Dr. Catherina Pinnaro

Why does diabetes happen in some children who have experienced pancreatitis? A new study from Dr. Larson Ode and Dr. Pinnaro, along with a former research fellow Dr. Parra Villasmil, delves into this very question, uncovering unexpected patterns. Their work has been just published in the Journal of Pediatric Gastroenterology and Nutrition. The manuscript, titled “Early mechanisms of diabetes development in pediatric pancreatitis – a pilot study”, explores the complex interplay between pancreatitis and diabetes risk in children. Diabetes is a serious complication for children with pancreatitis, affecting nearly 9% during childhood and up to half over a lifetime. Despite this high risk, little is known about the underlying mechanisms or biomarkers that predict which children are most vulnerable. This study takes an important step toward filling that gap. Their findings revealed that 35% of participants exhibited dysglycemia, often linked to insulin resistance. Could insulin resistance be the key mechanism that drives diabetes risk? Another surprise finding was that dysglycemia was associated with higher pancreatic polypeptide levels. These results will help inform future studies that could pave the way for earlier detection and/or targeted interventions to prevent diabetes in this high-risk population. The manuscript is indexed on PubMed at this URL.

Posted on

Inhaled Insulin Shows Some Benefits for Children with Type 1 Diabetes in Landmark Clinical Trial

Dr. Tansey

We are proud to announce our division’s contribution to a major clinical study recently published in Diabetes Care: “INHALE-1, A Multicenter Randomized Trial of Inhaled Technosphere Insulin in Children With Type 1 Diabetes.” One of our Division physicians, Dr. Tansey, served as a co-author on this important research. The INHALE-1 trial examined the safety and effectiveness of an inhaled form of insulin compared to standard rapid-acting insulin injections in 230 children and adolescents aged 4 to 17 living with diabetes. Over a 26-week period, participants continued their long-acting basal insulin and used continuous glucose monitoring while receiving either inhaled or injected rapid acting insulin. Compared to the injected insulin group, the inhaled insulin group experienced a similar hemoglobin A1c, similar continuous glucose monitor readings, and lung function. Children using TI reported greater treatment satisfaction and experienced less weight gain compared to those on injected insulin. These findings suggest that inhaled insulin could become a valuable option for some pediatric patients. It is important to note that the study did not compare inhaled insulin to insulin pump-based therapy. The manuscript abstract is available on Pubmed. We especially wish to thank the research coordinators, research participants and their families who made this study possible.

Posted on

Our Program Ranked Among the Best Children’s Diabetes & Endocrinology Programs Nationally

We are excited to share that our Division has been rated among the Best Children’s Hospitals for Diabetes & Endocrinology Care by the US News 2025-2026 annual national report, where we were ranked #33 nationwide. Other top ranked specialties at the University of Iowa Stead Family Children’s Hospital included neonatology (#19), nephrology, urology, pediatric cancer, and behavioral health.

“Our ongoing strong national ranking is a testament to the steadfast dedication and expertise of our pediatric endocrine physicians, nurse practitioners, specialty nurses, diabetes educators, psychologists, researchers, medical assistants, dieticians, pharmacists, social workers, and all teams members. We remain devoted to provide the best endocrine and diabetes care for the children and adolescents in the region and beyond.”

Andrew Norris, M.D. Ph.D.
Director, Division of Endocrinology and Diabetes
UI Stead Family Children’s Hospital

Posted on

Lifestyle Counseling for Adolescents by Physicians

Dr. Kanner

Lifestyle interventions can be a very powerful means to impact adolescent obesity. However lifestyle counseling of adolescence is notoriously difficult. Physicians are often poorly trained to meet this challenge. These discussions are fraught with some risk that insensitive approaches might trigger disordered eating and/or disturbed body image. To help physicians address these challenges, Dr. Lauren Kanner from our division is part of a team delivering a lecture entitled “Neither Feast nor Famine: Weight-Inclusive Approaches to Counseling Youth with Higher BMIs”. This lecture aims to provide physicians with strategies to effectively counsel adolescents to enact positive lifestyle changes. The lecture will be delivered by Dr. Kanner in conjunction with Dr. Maya Kumar from Rady Children’s Hospital. The lecture is co-sponsored by Society for Adolescent Health and Medicine (SAHM) and the North American Society for Pediatric & Adolescent Gynecology (NASPAG). The webinar will occur on October 8, 2025. See this link to sign up to view the webinar.

Posted on

Grand Rounds: Medical and Psychological Care for DSD

Dr. Akhila Ramakrishna

On September 19th, Dr. Ramakrishna from our division co-presented Pediatric Grand Rounds along with pediatric psychologist Dr. Laura Fuller. Their talk, entitled “Treating Patients with Differences of Sexual Development: The Intersection of Medicine and Psychology”, explored the complexities of the medical and psychological healthcare of Differences of Sexual Development (DSD).

DSDs encompass a group of conditions in which the typical processes of sexual development—anatomical, hormonal, functional, and reproductive—do not follow the usual male or female patterns. These variations may be apparent at birth or even prenatally, though some forms may not be diagnosed until adolescence or adulthood.

The primary goal of pediatric DSD care is to support the physical and emotional well-being of affected individuals during youth. During their presentation, Drs. Ramakrishna and Fuller provided an overview of the various types of DSDs and illustrated the unique medical and psychosocial needs of patients through case examples. They emphasized the importance of a multidisciplinary approach to care.

Drs. Ramakrishna and Fuller lead a multidisplinary DSD clinic that includes pediatric endocrinologists, pediatric urologists, clinical geneticists, and pediatric radiologists, with support from reproductive endocrinology and clinical pharmacy services.

We extend our sincere thanks to Drs. Ramakrishna and Fuller for their insightful presentation and for their leadership in delivering expert, compassionate DSD care through their multidisciplinary team.